200 related articles for article (PubMed ID: 15748208)
1. ISCOM-based vaccines: the second decade.
Sanders MT; Brown LE; Deliyannis G; Pearse MJ
Immunol Cell Biol; 2005 Apr; 83(2):119-28. PubMed ID: 15748208
[TBL] [Abstract][Full Text] [Related]
2. ISCOMs and ISCOMATRIX.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632
[TBL] [Abstract][Full Text] [Related]
3. Current status and potential application of ISCOMs in veterinary medicine.
Morein B; Hu KF; Abusugra I
Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
[TBL] [Abstract][Full Text] [Related]
4. ISCOMs: an adjuvant with multiple functions.
Sjölander A; Cox JC; Barr IG
J Leukoc Biol; 1998 Dec; 64(6):713-23. PubMed ID: 9850152
[TBL] [Abstract][Full Text] [Related]
5. ISCOM based vaccines for cancer immunotherapy.
Lenarczyk A; Le TT; Drane D; Malliaros J; Pearse M; Hamilton R; Cox J; Luft T; Gardner J; Suhrbier A
Vaccine; 2004 Feb; 22(8):963-74. PubMed ID: 15161073
[TBL] [Abstract][Full Text] [Related]
6. ISCOMATRIX adjuvant for antigen delivery.
Pearse MJ; Drane D
Adv Drug Deliv Rev; 2005 Jan; 57(3):465-74. PubMed ID: 15560952
[TBL] [Abstract][Full Text] [Related]
7. Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines.
Sjölander A; Cox JC
Adv Drug Deliv Rev; 1998 Dec; 34(2-3):321-338. PubMed ID: 10837684
[TBL] [Abstract][Full Text] [Related]
8. ISCOMs (immunostimulating complexes): the first decade.
Barr IG; Mitchell GF
Immunol Cell Biol; 1996 Feb; 74(1):8-25. PubMed ID: 8934649
[TBL] [Abstract][Full Text] [Related]
9. On the preparation, microscopic investigation and application of ISCOMs.
Myschik J; Lendemans DG; McBurney WT; Demana PH; Hook S; Rades T
Micron; 2006; 37(8):724-34. PubMed ID: 16750912
[TBL] [Abstract][Full Text] [Related]
10. Immune responses to ISCOM formulations in animal and primate models.
Sjölander A; Drane D; Maraskovsky E; Scheerlinck JP; Suhrbier A; Tennent J; Pearse M
Vaccine; 2001 Mar; 19(17-19):2661-5. PubMed ID: 11257406
[TBL] [Abstract][Full Text] [Related]
11. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
13. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.
Fossum C; Bergström M; Lövgren K; Watson DL; Morein B
Cell Immunol; 1990 Sep; 129(2):414-25. PubMed ID: 2383899
[TBL] [Abstract][Full Text] [Related]
14. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
[TBL] [Abstract][Full Text] [Related]
15. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
[TBL] [Abstract][Full Text] [Related]
16. In vivo activity of cationic immune stimulating complexes (PLUSCOMs).
McBurney WT; Lendemans DG; Myschik J; Hennessy T; Rades T; Hook S
Vaccine; 2008 Aug; 26(35):4549-56. PubMed ID: 18585421
[TBL] [Abstract][Full Text] [Related]
17. Adjuvanticity and ISCOM formation by structurally diverse saponins.
Bomford R; Stapleton M; Winsor S; Beesley JE; Jessup EA; Price KR; Fenwick GR
Vaccine; 1992; 10(9):572-7. PubMed ID: 1502835
[TBL] [Abstract][Full Text] [Related]
18. [Iscom (Immuno Stimulating Complex)-vaccine of equine influenza virus--transmission electron microscopic investigation and literature review].
Brügmann M; Drommer W; Reichl U; Boge A
Dtsch Tierarztl Wochenschr; 1997 Jun; 104(6):196-202. PubMed ID: 9303851
[TBL] [Abstract][Full Text] [Related]
19. Quaternary structure of the immunostimulating complex (iscom).
Ozel M; Höglund S; Gelderblom HR; Morein B
J Ultrastruct Mol Struct Res; 1989 Dec; 102(3):240-8. PubMed ID: 2634709
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems.
Sanina N; Chopenko N; Mazeika A; Kostetsky E
Biomed Res Int; 2017; 2017():4389525. PubMed ID: 28808657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
